Compound ID | 3138
Class: RNA synthesis inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Corynebacterium diphtheriae, and Neisseria gonorrhoeae (only Gram-negative it is active against); binds to DNA-dependent RNA polymerase |
| Propensity to select resistant mutants: | Yes |
| Description: | Natural product from Streptomyces tolypophorus; structure similar to rifamycin and streptovaricin; known to be unstable in acidic and alkaline media |
| Institute where first reported: | Alfa Farmaceutici S.p.A. Research Laboratories |
| Year first mentioned: | 1978 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/135451598 |
| Citation: | https://www.jstage.jst.go.jp/article/antibiotics1968/31/11/31_11_1195/_article/-char/en |